0001209191-16-115258.txt : 20160421
0001209191-16-115258.hdr.sgml : 20160421
20160421212709
ACCESSION NUMBER: 0001209191-16-115258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160419
FILED AS OF DATE: 20160421
DATE AS OF CHANGE: 20160421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 123 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 6503662626
MAIL ADDRESS:
STREET 1: 123 SAGINAW DRIVE
STREET 2: 123 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosen Robert
CENTRAL INDEX KEY: 0001555089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 161585139
MAIL ADDRESS:
STREET 1: C/O A.P. PHARMA, INC., 123 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-04-19
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001555089
Rosen Robert
123 SAGINAW DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
President
Common Stock
2016-04-19
4
M
0
176328
7.20
A
178968
D
Common Stock
2016-04-19
4
S
0
60925
22.4964
D
118043
D
Common Stock
2016-04-19
4
S
0
76949
23.4695
D
41094
D
Common Stock
2016-04-19
4
S
0
32224
24.486
D
8870
D
Common Stock
2016-04-19
4
S
0
6230
25.1104
D
2640
D
Common Stock
2016-04-20
4
M
0
4010
7.20
A
6650
D
Common Stock
2016-04-20
4
S
0
4010
22.1864
D
2640
D
Common Stock
2016-04-21
4
M
0
19662
7.20
A
22302
D
Common Stock
2016-04-21
4
S
0
19662
22.1459
D
2640
D
Employee Stock Option (Right to Buy)
7.20
2016-04-19
4
M
0
176328
0.00
D
2023-05-01
Common Stock
176328
948672
D
Employee Stock Option (Right to Buy)
7.20
2016-04-20
4
M
0
4010
0.00
D
2023-05-01
Common Stock
4010
944662
D
Employee Stock Option (Right to Buy)
7.20
2016-04-21
4
M
0
19662
0.00
D
2023-05-01
Common Stock
19662
925000
D
The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of August 20, 2015.
The range of sales prices received was $22.00 to $23.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $23.01 to $24.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $24.02 to $25.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $25.01 to $25.30. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $22.00 to $22.53. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $22.00 to $22.32. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
At the date of filing, 410,157 shares of the options granted pursuant to the underlying awards were fully vested and exercisable.
/s/ Brian Drazba
Attorney-in-fact for Robert Rosen
2016-04-21